Cargando…

Effect of hyperbilirubinaemia on neurocognitive, renal, bone and cardiovascular markers in HIV infection treated with boosted protease inhibitors

INTRODUCTION: Use of some protease inhibitors (PI) is associated with unconjugated hyperbilirubinaemia (HBR), due to inhibition of UGT1A1. As observed in Gilbert's syndrome, HBR may have antioxidant and anti-inflammatory effects. Inflammation may be relevant to neurocognitive (NC) impairment, c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barber, Tristan J, Moyle, Graeme, Hill, Andrew, Jagjit Singh, Gurmit, Boffito, Marta, Nelson, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P295
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225352/ https://www.ncbi.nlm.nih.gov/pubmed/25397571 http://dx.doi.org/10.7448/IAS.17.4.19827

Ejemplares similares

Impact of NRTI backbone on renal, bone and cardiovascular markers in HIV-infected individuals receiving a boosted protease inhibitor
por: Barber, Tristan, et al.
Publicado: (2014)

Immunogenicity of Two Doses of ChAdOx1 nCoV-19 Vaccine in Lung Transplant Recipients
por: Carlier, F.M., et al.
Publicado: (2022)

Le rapport neutrophiles/lymphocytes est-il utile pour prédire la mortalité au cours des pneumopathies à COVID-19
por: Ben Rhouma, C., et al.
Publicado: (2022)

Should the dose of tenofovir be reduced to 200–250 mg/day, when combined with protease inhibitors?
por: Hill, Andrew, et al.
Publicado: (2014)

Switching from ritonavir to cobicistat in HIV patients with renal impairment who are virologically suppressed on a protease inhibitor
por: Fisher, Martin, et al.
Publicado: (2014)

Co-administration of ritonavir-boosted protease inhibitors and rate of tenofovir discontinuation in clinical practice
por: Costarelli, Silvia, et al.
Publicado: (2014)

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysis
por: Zaccarelli, Mauro, et al.
Publicado: (2014)

The effect of tenofovir on renal function in HIV-positive pregnant women
por: Flanagan, Stuart, et al.
Publicado: (2014)

Protease mutations emerging on darunavir in protease inhibitor-naïve and experienced patients in the UK
por: El Bouzidi, Kate, et al.
Publicado: (2014)

Ultima llamada
por: González de la Garza, Mauricio
Publicado: (1981)

Nuevo entorno internacional : el PRI ante los retos
Publicado: (1990)

El último gobierno del PRI : balance del sexenio zedillista /
Publicado: (2000)

APRI and FIB-4 scores are not associated with neurocognitive impairment in HIV-infected persons
por: Libertone, Raffaella, et al.
Publicado: (2014)

The impact of nevirapine- versus protease inhibitor-based regimens on virological markers of HIV-1 persistence during seemingly suppressive ART
por: Kiselinova, Maja, et al.
Publicado: (2014)

Boosted lopinavir vs boosted atazanavir in patients failing a NNRTI first line regimen in an urban clinic in Kampala
por: Laker, Eva, et al.
Publicado: (2014)

Cardiovascular markers of inflammation and serum lipid levels in HIV-infected patients with undetectable viraemia
por: Viskovic, Klaudija, et al.
Publicado: (2014)

Ribavirin: Jaundice, hyperbilirubinaemia and renal failure: case report
Publicado: (2015)

Simulation of the impact of rifampicin on darunavir/ritonavir PK and dose adjustment strategies in HIV-infected patients: a population PK approach
por: Dickinson, Laura, et al.
Publicado: (2014)

Central nervous system penetration-effectiveness rank does not reliably predict neurocognitive impairment in HIV-infected individuals
por: Libertone, Raffaella, et al.
Publicado: (2014)

Learning from claims: hyperbilirubinaemia and kernicterus
por: Rennie, Janet M, et al.
Publicado: (2019)

Lamivudine plus darunavir boosted with ritonavir as simplification dual regimen in HIV-infected patients
por: Luis Casado, Jose, et al.
Publicado: (2014)

Transmitted antiretroviral drug resistance in treatment naïve HIV-infected persons in London in 2011 to 2013
por: McFaul, Katie, et al.
Publicado: (2014)

The nicotinic acid provocation test and unconjugated hyperbilirubinaemia.
por: Dickey, W., et al.
Publicado: (1991)

Hyperbilirubinaemia after cardiac surgery: the point of no return
por: Farag, Mina, et al.
Publicado: (2019)

CNS safety at 48-week of switching to ATV/r plus 3TC or two nucleos(t)ides in HIV-suppressed patients on stable ART: the SALT neurocognitive sub-study
por: Pérez Valero, Ignacio, et al.
Publicado: (2014)

Resistance mutations in protease gene at baseline are not related to virological failure in patients treated with darunavir/ritonavir monotherapy
por: Gutierrez-Liarte, Angela, et al.
Publicado: (2014)

Simplification to Stribild vs continuation of RTV-boosted DRV with FTC and TDF in virologically suppressed HIV adults: a STRATEGY-PI subgroup analysis
por: Arribas, Jose, et al.
Publicado: (2014)

Low level HIV viremia is more frequent under protease-inhibitor containing firstline therapy than under NNRTI-regimens
por: Wiesmann, Frank, et al.
Publicado: (2014)

Phototherapy for neonatal hyperbilirubinaemia: Unresolved aspects & future directions
por: Thomas, Niranjan, et al.
Publicado: (2021)

Coagulation profile of neonates with hyperbilirubinaemia in full-term newborns
por: Zhou, Fangye, et al.
Publicado: (2023)

Gag drug resistance mutations in HIV-1 subtype C patients, failing a protease inhibitor inclusive treatment regimen, with detectable lopinavir levels
por: Kelly Pillay, Sameshnee, et al.
Publicado: (2014)

Extreme neonatal hyperbilirubinaemia in refugee and migrant populations: retrospective cohort
por: Wouda, Eva Maria Nadine, et al.
Publicado: (2020)

Ratio of cord blood bilirubin and albumin as predictors of neonatal hyperbilirubinaemia
por: Sharma, Indra Kumar, et al.
Publicado: (2020)

Role of Hyperbilirubinaemia as a Predictor of Complicated Appendicitis in Paediatric Population
por: Koirala, Dinesh Prasad, et al.
Publicado: (2022)

Tackling cardiovascular co-morbidities in HIV-positive patients: who, how and where?
por: Rolls, Sophie, et al.
Publicado: (2014)

Mediterranean diet: the impact on cardiovascular risk and metabolic syndrome in HIV patients, in Lisbon, Portugal
por: Policarpo, Sara, et al.
Publicado: (2014)

Comparison of oxidative stress markers in HIV-infected patients on efavirenz or atazanavir/ritonavir-based therapy
por: Estrada, Vicente, et al.
Publicado: (2014)

The potential impact of new national guidance on primary prevention of cardiovascular disease in people living with HIV
por: Ahmed, Nadia, et al.
Publicado: (2014)

RESISTANCE TO GLUCOCORTICOSTEROID THERAPY IN PATIENTS WITH SARS-COV-2 INFECTION WITH ELEVATED MARKERS OF ENDOTOXEMIA
por: Beloglazov, V., et al.
Publicado: (2022)

The efficacy, pharmacokinetics, safety and cardiovascular risks of switching nevirapine to rilpivirine in HIV-1 patients: the RPV switch study
por: Rokx, Casper, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bg3u68k0tur2cpobemr24nmdii